4//SEC Filing
Wigzell Hans Lennart Rudolf 4
Accession 0001209191-23-045095
CIK 0000873303other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 8:00 PM ET
Size
9.1 KB
Accession
0001209191-23-045095
Insider Transaction Report
Form 4
Wigzell Hans Lennart Rudolf
Director
Transactions
- Sale
Common Stock
2023-08-04$106.72/sh−15,000$1,600,800→ 20,994 total - Exercise/Conversion
Stock Option (right to buy)
2023-08-04−15,000→ 0 totalExercise: $29.03From: 2015-02-28Exp: 2024-02-28→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2023-08-04$29.03/sh+15,000$435,450→ 35,994 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.42 to $107.04 per share. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001492766
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 8:00 PM ET
- Size
- 9.1 KB